Elektrokonvulzif Tedavi: Bir Güncelleme

Öz

Psikiyatrik hastalıkların tedavisinde kullanılmaya başlandığından beri elektrokonvulzif tedavinin etki ve yan etkileri tartışılmaktadır. Antidepresan etki mekanizmaları birçok araştırmaya konu olmuş, önemli bulgular elde edilmiştir. Ancak yöntemsel farklılıklar ve uygulama protokolündeki değişiklikler araştırmaların ilerlemesinin önünde en büyük engel olmuşlardır. Birçok araştırmada antikonvülzan etki ve nöbet eşiğindeki yükselme ölçü olarak alınmış olmasına karşın bu durum kesinleştirilememiştir. Hastalıklarla ilgili değişkenlerin araştırma bulgularını etkilemiş olma olasılığı bulunmaktadır. Bu yazıda elektokonvulzif tedavinin uygulama biçimleri ve etki mekanizmalarıyla ilgili güncel literatür incelenmiştir.

Anahtar Kelimeler

• EKT, etki mekanizması, nöbet eşiği, antikonvulzan etki

Electroconvulsive Therapy: An Update

Abstract

Effects and side effects of electroconvulsive therapy have been a subject of debate since the begininng of its use to treat psychiatric disorders. As its antidepressant mechanism of action have been topic of many researches, many valuable findings were obtained ever since. However, methodological differences and different application protocols limited the accumulation of scientific data. Anticonvulsant effect and elevation of seizure threshold have been taken as outcome measures in many researches although it is still controversial. Some variables of treated disorders also may have affected researches. The aim of this article was to investigate current literature regarding application protocols and mechanism of action of electroconvulsive therapy.

Keywords

• ECT, mechanism of action, seizure threshold, anticonvulsant effect

Kaynakça

1. Scott AF. Electroconvulsive therapy, practice and evidence. Br J Psychiatry 2010; 196:171-172.
2. Akdeniz F, Noyan MA. Elektrokonvülsif tedavinin diğer endikasyonları. Ege Psikiyat- ri Dergisi 1998; 3:279-284.
3. Cimilli C. EKT’nin alışılmışın dışında kullanım alanları. Turk Psikiyatr Derg, 1994; 5:279-282.
4. American Psychiatric Association (APA) Task Force on ECT. The practice of ECT: recommendations for treatment, training and privileging. Washington DC, American Psychiatric Association Press,1990.
5. Rabheru K. The use of electroconvulsive therapy in special patient populations. Can J Psychiatry 2001; 46:710-719.
6. Kısa C, Aydemir Ç. Elektrokonvulsif tedavinin etki mekanizması. Psikiyatri Psikoloji Psikofarmakoloji (3P) Dergisi 2003; 11(Ek 4):7-11.
7. Payne NA, Prudic J. Electroconvulsive therapy: Part I a perspective on the evolution and current practice of ECT. J Psychiatr Pract 2009; 15:346-368.
8. Kellner CH, Pritchett JT, Beale MD, Coffey, CE. Handbook of ECT. Washington DC, American Psychiatric Press, 1997.

9. Abrams R. Electroconvulsive therapy, 4th edition. New York, Oxford University Press, 2002.
10. Nobler MS, Sackeim HA. Neurobiological correlates of cognitive side effects of electroconvulsive therapy. J ECT 2008; 24:40-45.
11. Peterchev AV, Rosa MA, Deng ZD, Prudic J, Lisanby SH. Electroconvulsive therapy stimulus parameters: rethinking dosage. J ECT 2010; 26:159-174.
12. Sadock BJ, Sadock VA. Kaplan and Sadock's Synopsis of Psychiatry: Behavioral Sciences/Clinical Psychiatry (Synopsis of Psychiatry), 10th ed. Philadelphia, PA; Lippincott Williams & Wilkins, 2007.
13. Tomruk NB, Kutlar MT, Mengeş OO, Canbek O, Soysal H. Elektrokonvulsif Teda- vi Klinik Uygulama El Kitabı 1.Baskı, İstanbul, TC Sağlık Bakanlığı, 2007.
14. Maxwell RD. Electrical factors in ECT. Acta Psychiatry Scand 1968; 44:436-448.
15. Weinar RD. ECT and seizure threshold: effects of stimulus wave form and electrode placements. Biol Psychiatry 1980; 15:225-241.
16. Petrides G, Braga RJ, Fink M, Knapp MMR, Husain M, Rummans T et al. Seizure threshold in a large sample: ımplications for stimulus dosing strategies in bilateral ECT. J ECT 2009; 25:232-237.
17. Calev A, Nigal D, Shapira B, Tubi N, Chazan S, Ben-Yehuda Y et al. Early and long- term effects of ECT and depression on memory and other cognitive functions. J Nerv Ment Dis 1991; 179:526-533.
18. Öztürkoğlu M, Evlice YE, Özpoyraz N, Ünal M, Fettahlıoglu M. Elektrokonvülsif tedavinin antidepresan ekinliği ve yan etkileri. Türk Psikiyatri Derg 1994; 5:109-112.
19. Friedberg J. Shock treatment, brain damage and memory loss: a neurological perspective. Am J Psychiatry 1977; 134:1010-1014.
20. Fink M. Convulsive therapy: a review of first 55 years. J Affect Disord 2001; 63:1-5.
21. American Psychiatric Association. The Practice of ECT: Recommendations for Treatment, Training and Privileging. 2nd ed. Washington, DC, American Psychiatric Press, 2001.
22. Kalinowsky LB, Hippius H. Pharmacological, Convulsive and Other Somatic Treatments in Psychiatry. New York, Grune & Stratton, 1969.
23. Perugi G, Medda P, Zanello S, Toni C, Cassano GB. Episode length and mixed features as predictors of ECT nonresponse in patients with medication-resistant major depression. Brain Stimul 2011 doi:10.1016/j.brs.2011.02.003
24. Medda P, Perugi G, Zanello S, Ciuffa M, Rizzato S, Cassano GB. Comparative response to electroconvulsive therapy in medication-resistant bipolar I patients with depression and mixed state. J ECT 2010; 26:82-86.
25. Daly JJ, Prudic J, Devanand DP, Nobler MS, Lisanby SH, Peyser S et al. ECT in bipolar and unipolar depression: differences in speed of response. Bipolar Disord 2001; 3:95-104.
26. Sienaert P, Vansteelandt K, Demyttenaere K, Peuskens J. Ultra-brief pulse ECT in bipolar and unipolar depressive disorder: differences in speed of response. Bipolar Disord 2009;11:418-424.
27. Breggin PR. Brain disabiling treatments in psychiatry: Drugs, Electroshock, and the role of FDA. Springer, New York, 1997.
28. Sackeim HA, Lisanby SH, Nobler MS, Van Heertum RL, DeLaPaz RL, Mensh B. MRI hyperintensities and the vascular origins of the late life depression. In Progress in Psychiatry (Ed C Andrade):73-116. Yeni Delhi, Oxford University Press, 2000.
29. Nobler MS, Teneback CC, Nahas Z, Bohning DE, Shastri A, Kozel FA et al. Structural and functional neuroimaging of electroconvulsive therapy and transcranial magnetic stimulation. Depress Anxiety 2000; 12:144-56.
30. Greffe J, Lemoine P, Lacroix C, Brunon AM, Terra JL, Dalery J et al. Increased serum levels of neuron-specific enolase in epileptic patients and after electroconvulsive therapy--a preliminary report. Clin Chim Acta 1996; 244:199-208.
31. Berrouschot J, Rolle K, Kühn HJ, Schneider D. Serum neuron-specific enolase levels do not increase after electroconvulsive therapy. J Neurol Sci 1997; 150:173-176.
32. Agelink MW, Andrich J, Postert T, Würzinger U, Zeit T, Klotz P et al. Relation between electroconvulsive therapy, cognitive side effects, neuron specific enolase, and protein S-100. J Neurol Neurosurg Psychiatry 2001; 71:394-396.
33. Palmio J, Huuhka M, Laine S, Huhtala H, Peltola J, Leinonen E et al. Electroconvulsive therapy and biomarkers of neuronal injury and plasticity: serum levels of neuron-specific enolase and S-100b protein. Psychiatry Res 2010; 177:97- 100.
34. Dwork AJ, Arango V, Underwood M, Ilievski B, Rosoklija G, Sackeim HA et al. Absence of histological lesions in primate models of ECT and magnetic seizure therapy. Am J Psychiatry 2004; 161:576-578.
35. Dwork AJ, Christensen JR, Larsen KB, Scalia J, Underwood MD, Arango V et al. Unaltered neuronal and glial counts in animal models of magnetic seizure therapy and electroconvulsive therapy. Neuroscience 2009; 164:1557-15564.
36. Coffey CE, Figiel GS, Djang WT, Sullivan DC, Herfkens RJ, Weiner RD. Effects of ECT on brain structure: a pilot prospective magnetic resonance imaging study. Am J Psychiatry 1988; 145:701-706.
37. Coffey CE, Weiner RD, Djang WT, Figiel GS, Soady SA, Patterson LJ, Holt PD et al. Brain anatomic effects of electroconvulsive therapy: a prospective magnetic resonance imaging study. Arch Gen Psychiatry 1991; 48:1013-1021.
38. Bergsholm P, Larsen JL, Rosendahl K, Holsten F. Electroconvulsive therapy and cerebral computed tomography: a prospective study. Acta Psychiatr Scand 1989; 80:566-572.
39. Nordanskog P, Dahlstrand U, Larsson MR, Larsson EM, Knutsson L, Johanson A. Increase in hippocampal volume after electroconvulsive therapy in patients with depression: a volumetric magnetic resonance imaging study. J ECT 2010; 26:62-67.
40. Mander AJ, Whitfield A, Kean DM, Smith MA, Douglas RH, Kendell RE. Cerebral and brain stem changes after ECT revealed by nuclear magnetic resonance imaging. Br J Psychiatry 1987; 151:69-71.
41. Scott AI, Douglas RH, Whitfield A, Kendell RE. Time course of cerebral magnetic resonance changes after electroconvulsive therapy. Br J Psychiatry 1990; 156:551- 553.
42. Diehl DJ, Keshavan MS, Kanal E, Nebes RD, Nichols TE, Gillen JS. Post-ECT increases in MRI regional T2 relaxation times and their relationship to cognitive side effects: a pilot study. Psychiatry Res 1994; 54:177-184.
43. Kunigiri G, Jayakumar PN, Janakiramaiah N, Gangadhar BN. MRI T(2) relaxometry of brain regions and cognitive dysfunction following electroconvulsive therapy. Indian J Psychiatry 2007; 49:195-199.
44. Bolwig TG, Hertz MM, Holm-Jensen J. Blood-brain barrier during electroshock seizures in the rat. Eur J Clin Invest 1977;7:95-100.
45. Saito S, Yoshikawa D, Nishihara F, Morita T, Kitani Y, Amaya T et al. The cerebral hemodynamic response to electrically induced seizures in man. Brain Res 1995; 673:93-100.
46. Nobler MS, Oquendo MA, Kegeles LS, Malone KM, Campbell CC, Sackeim HA et al. Decreased regional brain metabolism after ect. Am J Psychiatry 2001; 158:305- 308.
47. Robin A, Binnie CD, Copas JB. Electrophysiological and hormonal responses to three types of electroconvulsive therapy. Br J Psychiatry 1985; 147:707-712.
48. Mervaala E, Könönen M, Föhr J, Husso-Saastamoinen M, Valkonen-Korhonen M, Kuikka JT et al. SPECT and neuropsychological performance in severe depression treated with ECT. J Affect Disord 2001; 66:47-58.
49. Bajc M, Medved V, Basic M, Topuzovic N, Babic D, Ivancevic D. Acute effect of electroconvulsive therapy on brain perfusion assessed by Tc99m- hexamethylpropyleneamineoxim and single photon emission computed tomography. Acta Psychiatr Scand 1989; 80:421-426.
50. Bonne O, Krausz Y, Shapira B, Bocher M, Karger H, Gorfine M et al. Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy. J Nucl Med 1996; 37:1075-1080.
51. Rosenberg R, Vorstrup S, Andersen A, Bolwig TG. Effect of ECT on cerebral blood flow in melancholia assessed with SPECT. Convuls Ther 1988; 4:62-73.
52. Silfverskiöld P, Risberg J. Regional cerebral blood flow in depression and mania. Arch Gen Psychiatry 1989; 46:253-259.
53. Nobler MS, Sackeim HA, Prohovnik I, Moeller JR, Mukherjee S, Schnur DB et al. Regional cerebral blood flow in mood disorders, III: treatment and clinical response. Arch Gen Psychiatry 1994; 51:884-897.
54. Enev M, McNally KA, Varghese G, Zubal IG, Ostroff RB, Blumenfeld H. Imaging onset and propagation of ECT-induced seizures. Epilepsia 2007; 48:238-244.
55. Schmidt EZ, Reininghaus B, Enzinger C, Ebner C, Hofmann P, Kapfhammer HP. Changes in brain metabolism after ECT-positron emission tomography in the assessment of changes in glucose metabolism subsequent to electroconvulsive therapy- -lessons, limitations and future applications. J Affect Disord 2008; 106:203-208.
56. Sermet E, Grégoire MC, Galy G, Lavenne F, Pierre C, Veyre L et al. Paradoxical metabolic response of the human brain to a single electroconvulsive shock. Neurosci Lett 1998; 254:41-44.
57. Woods BT, Chiu TM. In vivo 1H spectroscopy of the human brain following electroconvulsive therapy. Ann Neurol 1990; 28:745-749.
58. Felber SR, Pycha R, Hummer M, Aichner FT, Fleischhacker WW. Localized proton and phosphorus magnetic resonance spectroscopy following electroconvulsive therapy. Biol Psychiatry 1993; 33:651-654.
59. Weiner RD, Coffey CE, Krystal AD. The monitoring and management of electrically induced seizures. Psychiatr Clin North Am 1991; 14:845-869.
60. Sánchez González R, Alcoverro O, Pagerols J, Rojo JE. Electrophysiological mechanisms of action of electroconvulsive therapy. Actas Esp Psiquiatr 2009; 37:343- 351.
61. Sackeim HA, Luber B, Moeller JR, Prudic J, Devanand DP, Nobler MS. Electrophysiological correlates of the adverse cognitive effects of electroconvulsive therapy. J ECT 2000; 16:110-120.
62. Neuhaus AH, Gallinat J, Bajbouj M, Reischies FM. Interictal slow wave focus in left medial temporal lobe during bilateral electroconvulsive therapy. Neuropsychobiology 2005; 52:183-189.
63. Sackeim HA, Luber B, Katzman GP, Moeller JR, Prudic J, Devanand DP et al. The Effects of electroconvulsive therapy on quantitative electroencephalograms: relationship to clinical outcome. Arch Gen Psychiatry 1996; 53:814-824.
64. Sackeim HA. The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. J ECT 1999; 15:5-26.
65. Mann JJ. Neurobiological correlates of the antidepressant action of ECT. J ECT 1998; 14:172-180.
66. Yatham LN, Liddle PF, Lam RW, Zis AP, Stoessl AJ, Sossi V et al. Effect of electroconvulsive therapy on brain 5-HT(2) receptors in major depression. Br J Psychiatry 2010; 196:474-479.
67. Ishihara K, Sasa M. Mechanism underlying the therapeutic effects of electroconvulsive therapy on depression. Jpn J Pharmacol 1999; 80:185-189.
68. Kapur S, Austin MC, Underwood MD, Arango V, Mann JJ. Electroconvulsive shock ıncrease tyrosine hydroxilase and neuropeptit Y gene expression in the locus coeruleus. Mol Brain Res 1993; 18:121-126.
69. Morinobu S, Nibuya M, Duman RS. Chronic antidepressant treatment down- regulates the ınduction of c-fos mRNA in response to acute stres in rat frontal cortex. Neuropsychopharmacology 1995; 12:221-228.
70. Berrettini WH, Nurnberg JI Jr., Hare T, Gershon ES, Post RM. Plasma and CSF GABA in affective illness. Br J Psychiatry 1982; 141:483-487.
71. Gold BI, Bowers MB Jr., Roth RH, Sweeney DW. GABA levels in CSF of patients with psychiatric disorders. Am J Psychiatry 1980; 137:362-364.
72. Petty F, Kramer GL, Dunnam D, Rush AJ. Plasma GABA in mood disorders. Psychopharmacol Bull 1990; 26:157-161.
73. Gren AR. Changes in GABA biochemistry and seizure threshold. Ann NY Acad Sci 1986; 462:105-119.
74. Gren AR, Vincent ND. The effect of repeated electroconvulsive shock on GABA synthesis an release in regions of rat brain. Br J Pharmacol 1987; 92:19-24.
75. Sackeim HA, Prudic J, Devanand DP, Kiersky JE, Fitzsimons L, Moody BJ et al. Effect of stimulus intensity and electrode placement on the efficacy and cognitive effects of ECT. N Engl J Med 1993; 328:839-846.
76. Petty F. GABA and mood disorders: a brief review and hypothesis. J Affect Disord 1995; 34:275-281.
77. Bajbouj M, Lang UE, Neu P, Heuser I. Therapeutic brain stimulation and cortical excitability in depressed patients. Am J Psychiatry 2005;162:2192-2193.
78. Bajbouj M, Lang UE, Niehaus L, Hellen FE, Heuser I, Neu P. Effects of right unilateral electroconvulsive therapy on motor cortical excitability in depressive patients. J Psychiatr Res 2006; 40:322-327.
79. Chistyakov AV, Kaplan B, Rubichek O, Kreinin I, Koren D, Hafner H et al. Effect of electroconvulsive therapy on cortical excitability in patients with major depression: a transcranial magnetic stimulation study. Clin Neurophysiol 2005; 116:386-392.
80. Sanacora G, Mason GF, Rothman DL, Behar KL, Hyder F, Petroff OA et al. Reduced cortical gamma-aminobutyric acid levels in depressed patients determined by proton magnetic resonance spectroscopy. Arch Gen Psychiatry 1999; 56:1043- 1047.
81. Esel E, Kose K, Hacimusalar Y, Ozsoy S, Kula M, Candan Z et al. The effects of electroconvulsive therapy on GABAergic function in major depressive patients. J ECT 2008; 24:224-228.
82. Sanacora G, Mason GF, Rothman DL, Hyder F, Ciarcia JJ, Ostroff RB et al. Increased cortical GABA concentrations in depressed patients receiving ECT. Am J Psychiatry 2003; 160:577-579.
83. Sanacora G, Mason GF, Rothman DL, Krystal JH. Increased occipital cortex GABA concentrations in depressed patients after therapy with selective serotonin reuptake inhibitors. Am J Psychiatry 2002; 159:663-665.
84. Hesse GW, Teyler TJ. Reversible loss of hippocampal long term potentiation following electroconvulsive seizures. Nature 1976; 264:562-564.
85. Sackeim HA. The anticonvulsant hypothesis of the mechanisms of action of ECT: current status. J ECT 1999; 15:5-26.
86. Coffey CE, Lucke J, Weiner RD, Krystal AD, Aque M. Seizure threshold in electroconvulsive therapy (ECT) II. the anticonvulsant effect of ECT. Biol Psychiatry 1995; 37:777-788.
87. Kragh J, Tİnder N, Finsen BR, Zimmer J, Bolwig TG. Repeated electroconvulsive shocks cause transient changes in rat hippocampal somatostatin and neuropeptide Y immunoreactivity and mRNA in situ hybridization signals. Exp Brain Res 1994; 98:305-313.
88. Jiménez-Vasquez PA, Diaz-Cabiale Z, Caberlotto L, Bellido I, Overstreet D, Fuxe K et al. Electroconvulsive stimuli selectively affect behavior and neuropeptide Y (NPY) and NPY Y(1) receptor gene expressions in hippocampus and hypothalamus of Flinders Sensitive Line rat model of depression. Eur Neuropsychopharmacol 2007; 17:298-308.
89. Vezzani A, Schwarzer C, Lothman EW, Williamson J, Sperk G. Functional changes in somatostatin and neuropeptide Y containing neurons in the rat hippocampus in chronic models of limbic seizures. Epilepsy Res 1996; 26:267-279.
90. Tİnder N, Kragh J, Finsen BR, Bolwig TG, Zimmer J. Kindling induces transient changes in neuronal expression of somatostatin, neuropeptide Y, and calbindin in adult rat hippocampus and fascia dentata. Epilepsia 1994; 35:1299-1308.
91. Bolwig TG, Woldbye DP, Mikkelsen JD. Electroconvulsive therapy as an anticonvulsant: a possible role of neuropeptide Y (NPY). J ECT 1999; 15:93-101.
92. Mikkelsen JD, Woldbye DP. Accumulated increase in neuropeptide Y and somatostatin gene expression of the rat in response to repeated electroconvulsive stimulation. J Psychiatr Res 2006; 40:153-159.
93. Manji HK, Duman RS. Impairments of neuroplasticity and cellular resilience in severe mood disorders: implications for the development of novel therapeutics. Psychopharmacol Bull 2001; 35:5-49.
94. Nibuya M, Morinobu S, Duman RS. Regulation of BDNF and trkB mRNA in rat brain by chronic electroconvulsive seizure and antidepressant drug treatments. J Neurosci 1995; 15:7539-7547.
95. Angelucci F, Mathe´ AA, Aloe L. Neurotrophic factors and CNS disorders: findings in rodent models of depression and schizophrenia. Prog Brain Res 2004;146:151- 165.
96. Bocchio-Chiavetto L, Zanardini R, Bortolomasi M, Abate M, Segala M, Giacopuzzi M et al. Electroconvulsive Therapy (ECT) increases serum Brain Derived Neurotrophic Factor (BDNF) in drug resistant depressed patients. Eur Neuropsychopharmacol 2006; 16:620-624.
97. Fernandes B, Gama CS, Massuda R, Torres M, Camargo D, Kunz M et al. Serum brain-derived neurotrophic factor (BDNF) is not associated with response to electroconvulsive therapy (ECT): a pilot study in drug resistant depressed patients. Neurosci Lett 2009; 453:195-198.
98. Altar CA, Laeng P, Jurata LW, Brockman JA, Lemire A, Bullard J et al. Electroconvulsive seizures regulate gene expression of distinct neurotrophic signaling pathways. Neurosci 2004; 24:2667-2677.
99. Ploski JE, Newton SS, Duman RS. Electroconvulsive seizure-induced gene expression profile of the hippocampus dentate gyrus granule cell layer. J Neurochem 2006; 99:1122-1132.
100. Conti B, Maier R, Barr AM, Morale MC, Lu X, Sanna PP et al. Region-specific transcriptional changes following the three antidepressant treatments electro convulsive therapy, sleep deprivation and fluoxetine. Mol Psychiatry 2007; 12:167- 189.
101. Newton SS, Girgenti MJ, Collier EF, Duman RS. Electroconvulsive seizure increases adult hippocampal angiogenesis in rats. Eur J Neurosci 2006; 24:819-828.
102. Ende G, Braus DF, Walter S, Fahr WW, Henn FA. The hippocampus in patients treated with electroconvulsive therapy. Arch Gen Psychiatry 2000; 57:937-943.
103. Chen AC, Shin KH, Duman RS, Sanacora G. ECS-Induced mossy fiber sprouting and BDNF expression are attenuated by ketamine pretreatment. J ECT 2001; 17:27- 32
104. Moksnes KJ, Ilner SO. Electroconvulsive therapy –efficacy and side-effects. Tidsskr Nor Laegeforen 2010; 130:2460–2464.
105. Angelucci F, Aloe L, Jiménez-Vasquez P, Mathé AA. Electroconvulsive stimuli alter the regional concentrations of nerve growth factor, brain-derived neurotrophic factor, and glial cell line-derived neurotrophic factor in adult rat brain. J ECT 2002; 18:138- 143.
106. Lindefors N, Brodin E, Metsis M. Spatiotemporal selective effects on brain-derived neurotrophic factor and trkB messenger RNA in rat hippocampus by electroconvulsive shock. Neuroscience 1995; 65:661-670.
107. Duman RS, HeningerGR, Nestler EJ. A molecular and cellular theory of depression. Arch Gen Psychiatry 1997; 54:597-606.
108. Dziedzicka-Wasylewska M,Rogoz R. The effect of prolonged treatment with imipramine and ECT on the levels of endogenous enkephalins in the nucleus accumbens and ventral tegmentum of the rat. J Neural Transm 1995; 102:221-228.
109. Duman RS, Vaidya VA. Molecular and cellular actions of chronic electroconvulsive seizures. J ECT 1998; 14:181-193.
110. Stewart C, Reid I. Electroconvulsive stimulation and synaptic plasticity in the rat. Brain Res 1993; 620:139-141.
111. Stewart C, Jeffery K, Reid I. LTP-like synaptic efficacy changes following electroconvulsive stimulation. Neuroreport 1994; 5:1041-1044.
112. Anwyl R, Walshe J, Rowan M. Electroconvulsive treatment reduces long-term potentiation in rat hippocampus. Brain Res 1987; 435:377-379.
113. Stewart CA, Davies SN. Repeated electroconvulsive stimulation impairs synaptic plasticity in the dentate gyrus in vivo but has no effect in CA1 in vitro. Neurosci Lett 1996; 213:177-180.
114. Barnes CA, Jung MW, McNaughton BL, Korol DL, Andreasson K, Worley PF. LTP saturation and spatial learning disruption: effects of task variables and saturation levels. J Neurosci 1994; 14:5793-5806.
115. Nordanskog P, Dahlstrand U, Larsson MR, Larsson EM, Knutsson L, Johanson A. Increase in hippocampal volume after electroconvulsive therapy in patients with depression: a volumetric magnetic resonance imaging study. J ECT 2010; 26:62-67.
116. Bilgi MM, Eker Ç, Gönül AS. İdame elektrokonvulzif tedavi. Psikiyatride Güncel Yaklaşımlar 2010; 2:421-442.
117. Murat İlhan Atagün, Dr., Bakırköy Ruh ve Sinir Hastalıkları Hastanesi, İstanbul; Murat Serkan Yıldırım,
118. Dr., Bakırköy Ruh ve Sinir Hastalıkları Hastanesi, İstanbul; Özge Canbek, Dr., Bakırköy Ruh ve Sinir Hastalıkları Hastanesi, İstanbul